000 01441 a2200385 4500
005 20250513042828.0
264 0 _c19940614
008 199406s 0 0 eng d
022 _a0733-222X
024 7 _a10.1038/nbt0594-494
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaslow, D C
245 0 0 _aProduction, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.
_h[electronic resource]
260 _bBio/technology (Nature Publishing Company)
_cMay 1994
300 _a494-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aAntibodies, Protozoan
_xblood
650 0 4 _aGene Expression
650 0 4 _aGenetic Vectors
650 0 4 _aMalaria Vaccines
_xbiosynthesis
650 0 4 _aMalaria, Falciparum
_xprevention & control
650 0 4 _aMice
650 0 4 _aMolecular Sequence Data
650 0 4 _aPlasmids
650 0 4 _aPlasmodium falciparum
_ximmunology
650 0 4 _aProtozoan Proteins
_xchemistry
650 0 4 _aRecombinant Proteins
650 0 4 _aSaccharomyces cerevisiae
_xgenetics
650 0 4 _aVaccines, Synthetic
_xbiosynthesis
700 1 _aShiloach, J
773 0 _tBio/technology (Nature Publishing Company)
_gvol. 12
_gno. 5
_gp. 494-9
856 4 0 _uhttps://doi.org/10.1038/nbt0594-494
_zAvailable from publisher's website
999 _c7764076
_d7764076